Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria
Primaquine and tafenoquine are the only licensed drugs with activity against Plasmodium vivax hypnozoites but cause haemolysis in patients with glucose–6–phosphate dehydrogenase (G6PD) deficiency. Malaria also causes haemolysis, leading to the replacement of older erythrocytes with low G6PD activity...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-05-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094517/?tool=EBI |
Search Result 1
Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria.
Published 2022-05-01
Get full text
Article